Also trades as: BLRX.TA (TLV) · $vol 0M
BLRX NASDAQ
BioLineRx Ltd.
1W: -8.8%
1M: -13.5%
3M: -25.0%
YTD: -15.4%
1Y: -38.8%
3Y: -97.1%
5Y: -98.0%
$2.37
+0.02 (+0.85%)
Weekly Expected Move ±6.1%
$2
$2
$2
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$8M
+81.5% ▲
Capital Expenditures
$25K
+53.3% ▲
Free Cash Flow
-$8M
+81.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$7M
-216.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$27M | -$25M | -$61M | -$9M | -$1M |
| Depreciation & Amort. | $703K | $654K | $1M | $4M | $527K |
| Stock-Based Comp. | $1M | $2M | $2M | $1M | $0 |
| Change in Working Capital | -$540K | $1M | $15M | -$22M | $1M |
| Other Non-Cash Items | $39K | -$5M | $19M | -$18M | -$9M |
| Operating Cash Flow | -$24M | -$26M | -$23M | -$44M | -$8M |
| — Investing Activities — | |||||
| Capital Expenditures | -$97K | -$316K | -$116K | -$53K | -$27K |
| Acquisitions (Net) | $38K | -$4K | $0 | $0 | $0 |
| Investment Purchases | -$78M | -$44M | -$48M | -$26M | -$37M |
| Investment Sales | $40M | $48M | $49M | $56M | $28M |
| Other Investing | -$38K | $4K | -$181K | -$1K | $0 |
| Investing Cash Flow | -$38M | $4M | $1M | $29M | -$9M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4M | $6M | -$2M | $4M | -$5M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $11M | $5K | $3M | $22K | -$516K |
| Financing Cash Flow | $58M | $20M | $15M | $21M | $9M |
| Net Change in Cash | -$4M | -$2M | -$6M | $6M | -$7M |
| Cash End of Period | $13M | $11M | $4M | $10M | $3M |
| Free Cash Flow | -$24M | -$27M | -$23M | -$44M | -$8M |